Dr. Joseph R. Cuccia M.D.

Recommended Articles

• Can Supplements and Vitamins Help with Alzheimer’s Disease?

  Alzheimer’s disease is heartbreaking, and any suggestions or help is welcomed. There is no cure for Alzheimer’s and only a few medications are available for patients to ease the symptoms of the disease. It is a given that proper nutrition supports your brain and body function, plus vitamins and...

• Dealing with Anxiety and MS

  In relation to MS, anxiety can present itself, owing to the fear of the effects of MS as it progresses, and the challenges, losses, or adjustments that may be necessary as a result of MS. This fear usually comes as a threat to your sense of normal self. A sense of self refers to how you feel about...

• Sandra Day O’Connor, First Woman on the Supreme Court, Suffers from Dementia

  Sandra Day O'Connor, 88, was the first woman to serve as a justice on the United States Supreme Court. She was appointed to the post by the late President Ronald Reagan in 1981 and serviced as a critical swing vote for much of her tenure. O'Connor was known as a moderate conservative and was the...

• Remaining Positive After a Muscular Dystrophy Diagnosis

  After the onset of muscular dystrophy, you might profoundly feel depressed. Yet, as time goes by, people adjust to their new situation and re-evaluate their attitude towards their condition. In some cases, people may even be driven to greater achievements after learning their diagnosis. To begin...

• Is Restless Legs Syndrome Chronic?

  Restless legs syndrome is not chronic. RLS is a neurological movement disorder of the limbs. It is usually associated with sleep disruptions. Patients with RLS will usually report strange sensations, such as an urge to move their leg. This can become very bothersome, which can lead to physical as...

• Nortis Inc. Receives $688K to Revolutionize Multiple Sclerosis Treatment

  One Seattle-based technology recently revealed new clinical technology that could completely change the way multiple sclerosis is treated. The firm received $668,000 to develop an in-vitro blood barrier that mimics the human blood-brain barrier, an innovation that would make MS drug development more...